Over the past 12 months, $AKTS (Aktis Oncology Inc) received 3 mentions from 2 distinct FinTwit voices, with the first mention appearing on December 22, 2025. The biotech category dominated discussion of this ticker. Jacob Plieth (@jacobplieth) was the most active voice with 2 mentions, while Serenity (@aleabitoreddit) contributed 1 mention. The most recent mention occurred on March 24, 2026.

Initial discussion focused on Aktis Oncology's IPO plans in late December 2025, followed by post-IPO trading performance analysis in mid-January 2026. A subsequent mention in March 2026 positioned $AKTS within a broader landscape of lesser-known companies receiving US government funding, specifically noting $4 million allocated to the company as lead grant recipient for the "LADDER" project via the NEMC (National Electronics Manufacturing Consortium) Hub.